During the past decade, Instituto CAICI conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 12 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 9 clinical trials were completed. i.e. 180% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto CAICI" #1 sponsor was "Bristol-Myers Squibb" with 6 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Pfizer" with 5 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored and "Hoffmann-La Roche" with 4 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto CAICI" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator, "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator and "Abbott" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Instituto CAICI" are "HIV Infections" (5 trials), "Juvenile Idiopathic Arthritis" (5 trials), "Rheumatoid Arthritis" (5 trials), "Heart Failure" (2 trials) and "Lupus Erythematosus, Systemic" (2 trials). Many other conditions were trialed in "Instituto CAICI" in a lesser frequency.

Most popular intervention types in "Instituto CAICI" are "Drug" (33 trials), "Other" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Baricitinib" (4 trials), "Abatacept" (2 trials), "BMS-986165" (2 trials) and "Efavirenz" (2 trials). Other intervention names were less common.

The vast majority of trials in "Instituto CAICI" are 35 trials for "All" genders.

Currently, there are NaN active trials in "Instituto CAICI". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Instituto CAICI, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto CAICI, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".